NCT01893346 - Safety and Tolerability of Ceftazidime-Avibactam for Pediatric Patients With Suspected or Confirmed Infections | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions

Systemic Infections

Interventions

DRUG

CAZ-AVI

Single IV dose of Ceftazidime and Avibactam. Dosage regimen will vary depending on cohort.

Trial Locations (10)

Research Site, Little Rock

Research Site, Orange

Research Site, San Diego

Research Site, Louisville

Research Site, Omaha

Research Site, Akron

Research Site, Cleveland

Research Site, Toledo

Research Site, Houston

Research Site, Morgantown